NF-κB signalling proteins p50/p105, p52/p100, RelA, and IKKε are over-expressed in oesophageal squamous cell carcinomas

References

• Aggarwal BB. Nuclear factor-kB: the enemy within. Cancer Cell 2004;6: 203–8.
   PubMed Web of Science ®Google Scholar
• Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 2006; 13: 759–72.
   PubMed Web of Science ®Google Scholar
• Basseres DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25: 6817–30.
   PubMed Web of Science ®Google Scholar
• Adli M, Baldwin AS. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem 2006; 281: 26976–84.
   PubMed Web of Science ®Google Scholar
• Boehm JS, Zhao JJ, Yao J, et al Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007; 129: 1065–79.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Sovak MA, Bellas RE, Kim DW, et al Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997; 100: 2952–60.
   PubMed Web of Science ®Google Scholar
• Dejardin E, Deregowski V, Chapelier M, et al Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 1999; 18: 2567–77.
   PubMed Web of Science ®Google Scholar
• Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999; 5: 119–27.
   PubMed Web of Science ®Google Scholar
• Visconti R, Cerutti J, Battista S, et al Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene 1997; 15: 1987–94.
   PubMed Web of Science ®Google Scholar
• Ross JS, Kallakury BV, Sheehan CE, et al Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immuno reactivity with disease recurrence. Clin Cancer Res 2004; 10: 2466–72.
   PubMed Web of Science ®Google Scholar
• Tian F, Zang WD, Hou WH, Liu HT, Xue LX. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin (Shanghai) 2006; 38: 318–26.
   PubMed Web of Science ®Google Scholar
• Liu JF, Zhu GJ, Jamieson GG, et al NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2. Cancer Invest 2009; 27: 17–23.
   PubMed Web of Science ®Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, et al Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–7.
   PubMed Web of Science ®Google Scholar
• Yang GZ, Li L, Ding HY, Zhou JS. Cyclooxygenase-2 is over-expressed in Chinese esophageal squamous cell carcinoma, and correlated with NF-kappaB: an immunohistochemical study. Exp Mol Pathol 2005; 79: 214–8.
   PubMed Web of Science ®Google Scholar
• Abdel-Latif MM, O'Riordan J, Windle HJ, et al NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 2004; 239: 491–500.
   PubMed Web of Science ®Google Scholar
• O'Riordan JM, Abdel-latif MM, Ravi N, et al Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005; 100: 1257–64.
   PubMed Web of Science ®Google Scholar
• Farrow DC, Vaughan TL, Hansten PD, et al Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 97–102.
   PubMed Web of Science ®Google Scholar
• Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995; 76: 1116–9.
   PubMed Web of Science ®Google Scholar
• Keats JJ, Fonseca R, Chesi M, et al Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131–44.
   PubMed Web of Science ®Google Scholar
• Courtois G, Gilmore TD. Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 2006; 25: 6831–43.
   PubMed Web of Science ®Google Scholar